Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.
Chelsea K PikeMinhae KimKristina SchnitzerNathaniel MercaldoRobert EdwardsVitaly NapadowYi ZhangErin Janas MorrisseyZeynab AlshelhA Eden EvinsMarco L LoggiaJodi M GilmanPublished in: BMJ open (2022)
NCT05066308; ClinicalTrials.gov.
Keyphrases
- phase ii
- double blind
- placebo controlled
- study protocol
- clinical trial
- phase iii
- cerebral ischemia
- open label
- resting state
- white matter
- traumatic brain injury
- lipopolysaccharide induced
- randomized controlled trial
- lps induced
- functional connectivity
- blood brain barrier
- cognitive impairment
- subarachnoid hemorrhage
- brain injury
- inflammatory response
- multiple sclerosis